Skip to main content
AGEN
NASDAQ Life Sciences

Principal Accounting Officer Resigns from Agenus

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.48
Mkt Cap
$149.08M
52W Low
$2.71
52W High
$7.34
52W Position info
28% above low
Off High info
53% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

AGEN sits 28% above its 52-week low of $2.71.

Summary

Agenus Inc.'s Principal Accounting Officer, Austin Charette, is resigning effective May 29, 2026, marking a change in key financial leadership following recent positive financial and regulatory news.


Key Events · Executive and Board Changes · AGEN

  • Principal Accounting Officer Resigns

    Austin Charette, Senior Director, Financial Reporting and Compliance and Principal Accounting Officer, informed Agenus Inc. of his resignation, effective May 29, 2026.

  • Timing Follows Positive News

    This departure occurs shortly after Agenus reported strong Q1 2026 results and announced the closure of an SEC investigation, which had previously raised "going concern" doubts.


Analysis · AGEN · Life Sciences

The departure of Austin Charette, the Principal Accounting Officer, introduces uncertainty regarding the continuity of financial leadership. This follows a period where Agenus faced "going concern" doubts and an SEC investigation, both of which were recently addressed with positive Q1 results and the investigation's closure. While the resignation is not immediate, it marks a change in a critical financial reporting role.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AGEN was trading at $3.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $149.1M. The 52-week trading range was $2.71 to $7.34. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AGEN - Latest Insights

AGEN
Aug 28, 2026, 10:07 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $7.85
Real-time Price: $7.16 info
Change: -$0.690 (-9%) info
Market Cap: $322.346M info
AGEN
Aug 07, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.87
Real-time Price: $7.16 info
Change: +$0.290 (+4%) info
Market Cap: $322.346M info
AGEN
Aug 06, 2026, 7:52 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.71
Real-time Price: $7.16 info
Change: -$0.550 (-7%) info
Market Cap: $322.346M info
AGEN
Aug 06, 2026, 7:44 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.79
Real-time Price: $7.16 info
Change: -$0.630 (-8%) info
Market Cap: $322.346M info
AGEN
Jul 13, 2026, 6:43 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.95
Real-time Price: $7.16 info
Change: +$3.21 (+81%) info
Market Cap: $322.346M info